1. Academic Validation
  2. Highly Sensitive Flow Cytometry Biosensor with a High Signal-to-Background Ratio for FEN1 Analysis via Solid-Phase Interface-Mediated Primer Exchange Reaction Amplification

Highly Sensitive Flow Cytometry Biosensor with a High Signal-to-Background Ratio for FEN1 Analysis via Solid-Phase Interface-Mediated Primer Exchange Reaction Amplification

  • Anal Chem. 2025 Jan 14;97(1):464-472. doi: 10.1021/acs.analchem.4c04564.
Yong-Li Song 1 Xiang-Lan He 1 Yarong Guo 2 3 Li-Yun Ma 4 Ming Jiang 1 Li Xu 1 Xu Yu 1 Qi Mei 2 5
Affiliations

Affiliations

  • 1 Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.
  • 2 Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, Shanxi, China.
  • 3 Department of Digestive System Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, Shanxi, China.
  • 4 Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • 5 Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract

Flap Endonuclease 1 (FEN1) is a specific Enzyme capable of recognizing and cleaving triplex DNA structures and releasing 5'-flap fragments. It plays a crucial role in the DNA metabolism of cells, participating in DNA replication and the repair of damaged DNA. Additionally, FEN1 is overexpressed in various tumor tissues, promoting tumor progression and drug resistance through different regulatory mechanisms. However, few significant advancements have been made in sensitive analytical methods for detecting FEN1. Herein, in this study, we present a highly sensitive flow cytometry biosensor with solid-phase interface-mediated primer exchange reaction amplification (FCsperA) for FEN1 analysis. By comparing homogeneous PER amplification (h-PER), we found that solid-phase interface-mediated PER amplification (s-PER) effectively suppressed background signals, leading to a higher signal-to-background (S/B) ratio exceeding ∼46-fold when FEN1 was at 1 × 10-3 U/μL. Combining the high efficiency of s-PER, the strong suppression of background signals, and the highly precise flow cytometry assay, FCsperA showed high sensitivity, with a limit of detection (LOD) for FEN1 of 2.53 × 10-6 U/μL. Notably, FCsperA exhibited high selectivity and exceptional anti-interference ability, making it applicable for detecting FEN1 in cells and serum samples. The outstanding performance of FCsperA allowed for sensing FEN1 in ∼10 Cancer cells. Additionally, FCsperA demonstrated the potential for screening inhibitors of FEN1.

Figures
Products